KPC Pharmaceuticals Inc. logo

KPC Pharmaceuticals Inc. (600422)

Market Open
11 Aug, 06:57
SSE SSE
¥
8. 92
+0.11
+1.2486%
¥
13.07B Market Cap
- P/E Ratio
0.8% Div Yield
2.5M Volume
- Eps
¥ 8.81
Previous Close
Add Transaction
Day Range
8.76 8.93
Year Range
7.45 14.98
Want to track 600422 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600422 trading today higher at ¥8.92, an increase of 1.2486% from yesterday's close, completing a monthly increase of 13.198% or ¥1.04. Over the past 12 months, 600422 stock lost -29.2063%.
600422 pays dividends to its shareholders, with the most recent payment made on Jul 30, 2026. The next estimated payment will be in In 11 months on Jul 30, 2027 for a total of ¥0.18.
The last earnings report, released on Apr 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
KPC Pharmaceuticals Inc. has completed 4 stock splits, with the recent split occurring on May 09, 2016.
The company's stock is traded on one exchange.

600422 Chart

People also search for

SAIC Motor Corporation Limited
¥ 10.47
-0.0954%
Seres Group Co., Ltd.
¥ 55.54
-0.8745%
Great Wall Motor Co., Ltd.
¥ 15.68
-0.0637%
Fuyao Glass Industry Group Co., Ltd.
¥ 56.5
-0.159%
China Tourism Group Duty Free Corporation Limited
¥ 56.02
-0.3912%

KPC Pharmaceuticals Inc. (600422) FAQ

What is the stock price today?

The current price is ¥8.92.

On which exchange is it traded?

KPC Pharmaceuticals Inc. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600422.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, the market cap is 13.07B.

Has KPC Pharmaceuticals Inc. ever had a stock split?

KPC Pharmaceuticals Inc. had 4 splits and the recent split was on May 09, 2016.

KPC Pharmaceuticals Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Sun Zhi Qiang CEO
SSE Exchange
CNE0000015P8 ISIN
CN Country
5,051 Employees
30 Jul 2026 Last Dividend
9 May 2016 Last Split
16 Nov 2000 IPO Date

Overview

KPC Pharmaceuticals, Inc. is a significant player in the pharmaceutical industry, focusing on the research and development, production, marketing, and commercial wholesale of botanical drugs. Its operations span across the People's Republic of China and have an international reach. Founded in 1951 and originally known as Kunming Pharmaceutical Corporation, it rebranded to KPC Pharmaceuticals, Inc. in April 2015. The company's headquarters are situated in Kunming, the People's Republic of China. It holds a distinguished position in the market for its advancement in botanical drugs and a wide array of product offerings catering to diverse medical needs.

Products and Services

Artemisia Annua Series: These products are based on the Artemisia annua plant, known for its efficacy in malaria treatment. KPC Pharmaceuticals develops artemisinin antimalarials, which have been pivotal in combating malaria globally.

Panax Notoginseng Products: These involve formulations derived from Panax notoginseng, a herb known for its benefits in stopping bleeding and dispersing blood stasis, often used in traditional Chinese medicine.

Gastrodia Products: KPC offers products derived from Gastrodia elata, a traditional Chinese herb used to treat headaches, convulsions, and other neurological conditions.

Specialty Herbal Products: This category includes a variety of specialized herbal remedies tailored for different health concerns, showcasing KPC Pharmaceuticals' expertise in herbal medicine.

Fine Chinese Products: KPC manufactures a range of high-quality Chinese herbal medicines that adhere to traditional preparation methods, ensuring authenticity and effectiveness.

Classic Prescription for Bones and Joint: These products are based on classic Chinese medical prescriptions aimed at treating bones and joint problems, utilizing the long-standing wisdom of Chinese medicine.

Antibiotic, Immunosuppressive Products: Beyond traditional herbal formulations, KPC also produces antibiotics and immunosuppressive drugs to meet various healthcare needs.

Medicine and Food Series: Leveraging the principle of food as medicine, this series integrates dietary and medicinal knowledge to promote health and well-being.

Skin Care Products: KPC offers a range of skin care products that aim at improving skin health with natural ingredients and traditional formulations.

Oral Care Products: This line includes products designed for oral hygiene and health, formulated using traditional Chinese medicine principles.

Private Care Products: Catering to personal care needs, this series includes products for intimate hygiene, combining modern science with traditional herbal wisdom.

Time-Honored Food Series: Reviving ancient food recipes with medicinal properties, these products blend nutrition with traditional Chinese dietary therapy.

Other Products: KPC’s portfolio also includes oral medications and injections, offering a broad spectrum of healthcare solutions, including generic drugs and medical apparatus, demonstrating the company's extensive involvement in improving global health.

Contact Information

Address: No.166 Keyi Road, Kunming, China, 650106
Phone: 86 871 6831 9868